Voyager Therapeutics, Inc. (VYGR)
NASDAQ: VYGR · Real-Time Price · USD
4.280
-0.070 (-1.61%)
Dec 5, 2025, 4:00 PM EST - Market closed
Voyager Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | -126.78 | -65 | 132.33 | -46.41 | -71.2 | 36.74 | |
| Depreciation & Amortization | 4.02 | 4.73 | 4.44 | 6.19 | 5.17 | 3.82 | |
| Loss (Gain) From Sale of Assets | 0.11 | 0.51 | 0.18 | 0.38 | - | - | |
| Asset Writedown & Restructuring Costs | - | 2.78 | - | - | - | - | |
| Loss (Gain) From Sale of Investments | -3.96 | -7.97 | -3.63 | -0.02 | 0.35 | 0.03 | |
| Stock-Based Compensation | 15 | 14.79 | 11.15 | 9.34 | 11.32 | 14.93 | |
| Other Operating Activities | 0.19 | - | - | -2.47 | -2.46 | -7.7 | |
| Change in Accounts Receivable | 15.63 | 81.31 | -83.23 | 0.48 | 7.28 | 10.48 | |
| Change in Accounts Payable | -1.04 | 2.39 | -0.96 | 1.99 | -0.06 | -3.44 | |
| Change in Unearned Revenue | -22.73 | -44.84 | 9.41 | 23.73 | -1.72 | -150.68 | |
| Change in Other Net Operating Assets | 2.83 | -4 | 8.23 | -5.73 | -2.21 | -0.91 | |
| Operating Cash Flow | -116.73 | -15.31 | 77.92 | -12.51 | -53.53 | -96.72 | |
| Capital Expenditures | -2.13 | -3.52 | -3.26 | -2.49 | -1.61 | -12.1 | |
| Investment in Securities | 52.94 | -91.34 | -138.39 | -4.85 | 67.52 | 125.09 | |
| Investing Cash Flow | 50.82 | -94.86 | -141.64 | -7.34 | 65.91 | 113 | |
| Issuance of Common Stock | 1.25 | 114.02 | 33.65 | 1.11 | 0.61 | 3.16 | |
| Financing Cash Flow | 1.25 | 114.02 | 33.65 | 1.11 | 0.61 | 3.16 | |
| Net Cash Flow | -64.66 | 3.85 | -30.08 | -18.74 | 12.99 | 19.44 | |
| Free Cash Flow | -118.86 | -18.83 | 74.66 | -15 | -55.13 | -108.81 | |
| Free Cash Flow Margin | -379.54% | -23.54% | 29.86% | -36.67% | -147.36% | -63.59% | |
| Free Cash Flow Per Share | -2.03 | -0.33 | 1.68 | -0.39 | -1.46 | -2.91 | |
| Levered Free Cash Flow | -62.89 | 25.61 | -3.01 | 7.25 | 3.94 | -19.99 | |
| Unlevered Free Cash Flow | -62.89 | 25.61 | -3.01 | 7.25 | 4.18 | -19.99 | |
| Change in Working Capital | -5.32 | 34.86 | -66.56 | 20.47 | 3.29 | -144.54 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.